Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 15Lung Neoplasms 11Colonic Neoplasms 10Breast Neoplasms 9Brain Neoplasms 7Prostatic Neoplasms 4Emergence Delirium 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Respiratory Aspiration 3Rectal Neoplasms 3Pituitary Neoplasms 3Neoplastic Cells, Circulating 3Hypoxia 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Supratentorial Neoplasms 2Postoperative Complications 2Patient Satisfaction 2Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Leukemia 2Delirium 2Colorectal Neoplasms 2Abdominal Neoplasms 2

Interventions

Tea 1Surveys and Questionnaires 1Propofol 1Midazolam 1Methods 1Fluorodeoxyglucose F18 1Fentanyl 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Respiration Disorders × Propofol × Clear all
NCT00004424 2015-03-25

Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy

FDA Office of Orphan Products Development

Phase NA Completed
120 enrolled

Respiration Disorders, Rare Diseases, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡